Human Natural Killer Cells: Origin, Clonality, Specificity, and Receptors

Lorenzo Moretta,Ermanno Ciccone,Maria Cristina Mingari,Roberto Biassoni,Alessandro Moretta

DOI: https://doi.org/10.1016/s0065-2776(08)60513-1

IF: 5.324

1993-01-01

Advances in Immunology

Abstract:Publisher This chapter focuses on human natural killer (NK) cells. NK cells are considered as effector cells that lyse tumor cells or virally infected cells via nonspecific mechanisms. Both their cytolytic effect and the spectrum of their antitumor activity are greatly increased after culture of NK cells in interleukin- 2 (IL-2). IL-2-activated NK cells represent the most potent effector cells among the lymphokine-activated killer (LAK) cells. Several of the generally accepted theories concerning NK cells have been challenged by evidence based on a variety of new experimental approaches and technological breakthroughs. NK cells may originate from precursors present in early fetal liver and even in immature postnatal thymocytes. They specifically recognize class I molecules. Different from T cells, binding of NK cells to class I molecules appears to result in a “negative signal” leading to target cell protection. Many tumor cells that are susceptible to lysis mediated by NK/LAK cells express normal amounts of surface class I antigens. This phenomenon is explained in that (1) the tumor cells express class I antigens that do not function as specific protective elements for the allogeneic NK cells most frequently used in the cytolytic assays and (2) the tumor cells may lack the expression of single class I alleles functioning as protective elements. The ability of activated NK cells to lyse efficiently a wider spectrum of tumor cells can be interpreted as the expression of appropriate activation receptors on these cells as a consequence of cell activation.

immunology